Documented reports about T helper type 17 (Th17) cells have revealed that Th17 plays a critical role in inflammation and autoimmunity diseases. However, the role of Th17 in cancer remains contradictory. The interplay between Th17 and tumour cells in the tumour microenvironment of primary hepatic carcinoma (PHC) needs to be explored further and the relationship between Th17, regulatory T cells (T regs ) and regulatory B cells (B regs ) has not been defined completely. In this study, numerous experiments were undertaken to elucidate the interaction of Th17 and T reg / B reg cells involved in PHC. Our work demonstrated that an increased Th17 was detected in the peripheral circulation and in tumour tissues in PHC patients. In addition, increases in peripheral blood Th17 corresponded with tumour-node-metastasis (TNM) stage progression. Also, further studies indicated that Th17 cells were promoted by tumour cells in the PHC tumour microenvironment through both contact-dependent andindependent mechanisms, but cell-contact played the major important role in promoting the production and proliferation of Th17. 
Summary
Documented reports about T helper type 17 (Th17) cells have revealed that Th17 plays a critical role in inflammation and autoimmunity diseases. However, the role of Th17 in cancer remains contradictory. The interplay between Th17 and tumour cells in the tumour microenvironment of primary hepatic carcinoma (PHC) needs to be explored further and the relationship between Th17, regulatory T cells (T regs ) and regulatory B cells (B regs ) has not been defined completely. In this study, numerous experiments were undertaken to elucidate the interaction of Th17 and T reg / B reg cells involved in PHC. Our work demonstrated that an increased Th17 was detected in the peripheral circulation and in tumour tissues in PHC patients. In addition, increases in peripheral blood Th17 corresponded with tumour-node-metastasis (TNM) stage progression. Also, further studies indicated that Th17 cells were promoted by tumour cells in the PHC tumour microenvironment through both contact-dependent andindependent mechanisms, but cell-contact played the major important role in promoting the production and proliferation of Th17. When isolated 
Introduction
Primary hepatic carcinoma (PHC) is one of the most prevalent and lethal malignancies in the world [1, 2] . Although it is the fifth most common cancer worldwide and the third most common cause of cancer-related death [3] , the relative mechanisms by which the immune system is modulated in patients with PHC remains largely unclear. T helper type 17 (Th17) cells and their effector cytokines are being recognized increasingly as key players in inflammation and autoimmune diseases [4, 5] . Although investigations into Th17 cells have been made for several years, the roles of Th17 cells in tumour immunity are still inconsistent. As to the function of Th17 cells in tumours, it has been shown that Th17 cells can promote tumour growth or might potentially mediate an anti-tumour effect [6] [7] [8] [9] [10] , so the precise expression of Th17 cells in tumour progression remains unclear and the exact role of Th17 in tumour immunity remains undefined and needs to be explored further.
Regulatory cells include regulatory T cells (T regs ) and regulatory B cells (B regs ). As we know, T reg cells play important roles in immune regulations [11, 12] . The immune suppressive roles of T regs in the development and progression of cancer have also been studied extensively [13, 14] .
In addition to T regs , a newly confirmed subset of B cells, described as CD19
1 CD1d hi CD5 1 [15] or CD19 1 CD24 hi CD38 hi [16] , has recently been at the forefront of investigation and plays an important regulatory role in autoimmune diseases and tumours [15] [16] [17] [18] .
In this study we quantified the percentage of Th17 cells in PHC, and investigated the potential relationship and mechanisms behind the interplay between the levels of Th17 cells and the development of PHC in humans. In addition, the relationship between Th17 and T regs (or B regs ) will be investigated in patients with PHC. To our knowledge, this study is the first to elaborate the relationship between Th17 and B regs in human PHC.
Materials and methods

Patients and specimens
Patients with PHC (n 5 93, 13 females and 80 males, mean age 5 49Á02 years, age range from 26 to 75 years) without previous treatments were enrolled into the study upon giving informed consent. According to the tumour-nodemetastasis (TNM) classification for primary hepatic carcinoma (Union for International Cancer Control, UICC 2010, 7th edition), the patients were divided into four stages: stage I (n 5 11, 11Á83%), stage II (n 5 28, 30Á11%), stage III (n 5 40, 43Á01%) and stage IV (n 5 14, 15Á05%). Closely age-matched, healthy volunteers (n 5 51, 12 males and 39 females, mean age5 46Á00 years, age range from 25 to 77 years) were recruited as healthy controls. Tumour tissues, peritumoral tissues (at least 2 cm distant from the tumour site) and tumour-free tissues (at least 4 cm distant from the tumour site) were obtained intra-operatively from 15 patients. This study was approved by the ethical committees of Changhai Hospital and the Eastern Hepatobiliary Hospital of the Second Military Medical University.
Cell preparation
Peripheral blood mononuclear cells (PBMC), CD4
1 T cells, tumour infiltrating lymphocytes (TIL), non-tumour infiltrating lymphocytes (NIL), CD14 1 monocyte cells, tumour cells and non-tumour cells were isolated from peripheral blood or tumour tissues. As monocytes are indicated to enhance Th17 cell levels [19] , CD14 1 cells were depleted from cells obtained from tumour and non-tumour tissues to avoid the effect of monocytes/macrophages. Detailed isolation is described in the Supporting information, Table S1 .
Flow cytometry analysis and cell sorting
Detailed activation and incubation of the cells mentioned previously are described in Supporting information, Table  S1 . The following anti-human antibodies were used: CD4 
RNA extraction and real-time polymerase chain reaction (PCR)
The sequences of primers are listed in Table 1 and Supporting information, Table S1 . Total RNA was extracted from PBMC with TRIzol (Invitrogen), according to the manufacturer's instructions. The RNA was quantified using a NanoDrop-2000 spectrophotometer (Thermo Scientific, Fremont, CA, USA), and 500 ng total RNA was reversetranscribed to cDNA using SYBR PrimeScript RT reagent Kit (Takara, Shiga, Japan), according to the manufacturer's instructions. The real-time PCR reactions were performed with the Rotor-Gene 6000 real-time PCR system using SYBR Premix Ex Taq from Takara following the manufacturer's recommendations. Relative expression was determined using the 2 -DDCt method with averaged relative levels of b-actin used for normalization.
Immunohistochemistry and confocal microscopy PHC tissues were fixed in 4% paraformaldehyde and embedded in paraffin. Paraffin-embedded samples were cut into 3-lm sections and resected specimens were dewaxed in xylene, rehydrated, washed in distilled water and then stained with haematoxylin and eosin (H&E). Immunohistochemical staining was performed as described previously [17, 20] . Briefly, sections were deparaffinated in xylene and rehydrated. Antigen retrieval was achieved by autoclaving in 1 mM ethylenediamine tetraacetic acid (EDTA) (pH 8Á0) at 1218C for 10 min. Endogenous peroxidase was blocked with 3% H 2 O 2 for 5 min and non-specific staining was prevented by soaking in 5% bovine serum albumin (BSA; Nacalai Tesque, Kyoto, Japan). Sections were stained overnight at 48C with mouse antihuman CD4 (at a 1 : 40 dilution; Novocastra, Newcastle upon Tyne, UK) and rabbit anti-human IL-17 (at a 1 : 100 dilution; Santa Cruz Biotechnology, Santa Cruz, CA, USA). After washing in PBS, the samples were incubated with secondary antibodies: FITC-conjugated goat anti-mouse immunoglobulin (Ig)G at a 1 : 200 dilution and PE-conjugated goat anti-rabbit IgG at a 1 : 100 dilution (all from Sigma, St Louis, MO, USA) for 30 min at room temperature before washing with PBS. Images were viewed and assessed using a scanning confocal microscopy (LSM510 META; Zeiss, Jena, Germany) and analysed by LSM510 META software. The mean fluorescence intensity (MFI) of CD4 and IL-17 were analysed with Image J (National Institutes of Health, Bethesda, MD, USA).
Transwell and cell co-culture systems
A contact-independent co-culture system was set up using Transwell inserts in which the two chambers were separated by a semipermeable membrane. The tumour cells were seeded at a density of 4 3 10 4 cells/well in 24-well plates and cultured overnight. A Transwell insert membrane with a 0Á4 lm poresize (Millipore, Burlington, MA, USA) was set in the well before autologous 4 3 10 5 cells/well CD4 1 T cells were added to the upper chamber. CD4 1 T cells were also cultured with tumour cells at a ratio of 10 : 1 in the cell-contact co-culture system. All the cells were co-cultured for 4 h in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 lg/ml streptomycin, after which the CD4 1 T cells were incubated with CD4 PE-Cy5Á5, IL-17A PE for Th17 detection and analysed by flow cytometry, as described previously.
Neutralization assay
Neutralization antibodies were diluted in PBS according to the manufacturer's instructions. To block IL-23, IL-6 and transforming growth factor (TGF)-b, tumour cells were incubated with isotypes or anti-human IL-23p19 neutralizing monoclonal antibodies (mAb) (R&D Systems, Minneapolis, MN, USA; final concentration of 5 lg/ml), anti-IL-6 (Millipore; final concentration of 10 lg/ml) and anti-TGF-b mAb (Millipore; final concentration of 10 lg/ml) singly or in combination for 1 h in the Transwell co-culture system before autologous CD4 1 T cells were seeded. Mouse IgG or anti-CD80, anti-CD86 and anti-ICOSL (all from Ancell, Stillwater, MN, USA; final concentration of 10 lg/ml) were incubated with tumour cells for 1 h singly or in combination in the direct-cell-contact co-culture system. CD4 1 T cells were then added to both culture systems. All the cells were cocultured for 48 h in DMEM containing 10% FBS, 100 U/ml penicillin and 100 lg/ml streptomycin, after which the CD4 1 T cells were incubated with CD4 PE-Cy5Á5, IL-17A PE for Th17 detection.
Statistical analysis
The results are expressed as means 6 standard deviation (s.d.). Statistical analyses were performed using the GraphPad Prism version 5Á0 software package (GraphPad Software, San Diego, CA, USA). Differences between groups were analysed using linear regression, t-test (Mann-Whitney U-test or paired test, two groups) or one-way analysis of variance (ANOVA) (Kruskal-Wallis test and Dunn's multiple comparison test, more than two groups). All tests were two-sided and significance was determined when P < 0Á05 (*P < 0Á05, **P < 0Á01 and ***P < 0Á001).
Results
Significantly increased Th17 cells in peripheral blood correlate with PHC TNM stage PBMC in patients with PHC (n 5 93) and in healthy volunteers (n 5 51) were examined for the prevalence of Th17 cells. The Th17 cell population as a percentage of total CD4 1 T cells was evaluated by flow cytometry. Representative plots showed that the Th17 cell populations in the gated CD4
1 cells were increased in the patients with PHC in comparison to normal controls (Fig. 1a) . Summarized data from all individuals indicated that the proportion of Th17 cells in the peripheral blood of PHC patients was , RAR-related orphan receptor C (RORc) and transforming growth factor (TGF)-b were higher than that in NC (*P < 0Á05; **P < 0Á01; ***P < 0Á001, respectively). [Colour figure can be viewed at wileyonlinelibrary.com] significantly higher than that in healthy donors (4Á621 6 0Á856% versus 3Á148 6 0Á716%, P < 0Á001, Fig. 1a ). In PBMC, compared with normal controls (NC), PHC expressed extremely high MFI levels of IL-17 (P < 0Á001, Fig. 1b) .
The clinical characteristics of the study subjects are summarized in Table 2 . The potential relationship between increased peripheral blood Th17 cells and the clinical characteristics of the 93 patients, including gender, age, the diameter and number of the tumours, portal vein tumour thrombosis (PVTT), metastasis, the preoperative concentration of AFP and TNM stages were analysed. The percentage of Th17 cells in PHC patients correlated positively with tumour size, PVTT and especially the TNM stages (P < 0Á05 for each group). The average percentage of Th17 cells in PHC patients was increased with TNM stage progression (I < II < III < IV, P < 0Á001), where Th17 cells in patients with advanced stages of PHC (III-IV) were significantly higher than those in the early stages (I-II) (P < 0Á01, Fig. 1c ). These observations indicated that the patients with advanced PHC had an increased population of Th17 cells in their PBMC. The mRNA expression levels of Th17-related factors in PBMC from PHC patients and normal controls were investigated using real-time PCR. Increased expression of IL-1R, IL-6, IL-17A, IL-17F, IL-21, IL-22, IL-23p19, retinoic acid-related orphan receptor C (RORc) and TGF-b mRNA was observed in PHC (P < 0Á05 for each group, Fig. 1d ). All these results suggested that Th17 cells were enriched in the peripheral blood of PHC patients, and increased Th17 population was correlated positively with PHC TNM stage.
Th17 cells accumulated in situ in PHC tumours
To examine the distribution of Th17 cells in different liver sites, H&E staining, fluorescence labelling and confocal microscopy were used. We demonstrated that compared with peritumoral tissues, more lymphocytes infiltrated into tumour tissues were detected in the intrahepatic region (Fig. 2a,b) . To visualize the distribution of liver-infiltrating Th17 cells, we used double immunostaining: CD4 and IL-17. Greatly infiltrated CD4
1 IL-17 1 Th17 cells were found in the lobular and portal areas of the livers in PHC tumour tissues (Fig. 2c) , whereas the liver tissues from autologous peritumoral tissue controls had few Th17 cells (Fig. 2d) . 
Tumour cells promote the proliferation of Th17 cells via cell-contact in PHC
In addition, isolated Th17 cells stained with CFSE were cocultured with or without autologous tumour cells from tumour tissues or non-tumour cells from peritumoral tissues for 7 days. Significant proliferation was found in Th17 cells co-cultured with tumour cells (Fig. 3a) . As we showed that tumour cells play important roles in promoting Th17 cells, to investigate this issue further purified CD4 1 T cells were left untreated or cultured with autologous tumour cells for 48 h in cell-contact-dependent or cell-contactindependent conditions. Here, we observed that the tumour cells enhanced the IL-17 production in both systems, but the proportion of IL-17 in the direct-contact coculture system was much higher than that in the Transwell co-culture system (Fig. 3b) . Our findings clearly support the emerging concept that tumour environmental factors drive the generation and expansion of Th17 cells. We therefore investigated which factors were involved in elevating Th17 cells in tumours.
Given that cell-contact-independent enhancement of Th17 cells in the tumour microenvironment is possible, we hypothesized that tumour cells and the tumour microenvironment create an optimal cytokine milieu to facilitate *P < 0Á05; **P < 0Á01; ***P < 0Á001. AFP 5 alpha-fetoprotein; TNM 5 tumour-node-metastasis. human CD4 1 T cell activation. As shown in Supporting information, Fig. S2 , we observed that co-stimulatory molecules such as CD80 and CD275 (ICOSL) were expressed highly by tumour cells. To remove the effect of ICOSL, CD80 and CD86, tumour cells were incubated with neutralizing antibodies to ICOSL, CD80 and CD86 singly or in combination for 1 h before CD4 1 T cells were added to the cell direct-contact co-culture system. Two days later, Th17 cells were analysed by flow cytometry. Intriguingly, the proportion of Th17 cells was decreased by the blocking antibody (Fig. 3c) . Thus, elevated Th17 cells in the tumour microenvironment may be regulated by membrane co-stimulatory molecules (CD80, CD86 and ICOSL) expressed on tumour cells.
Th17 increased with Treg and Breg in PHC
To avoid the effect of cytokines in the cell-contact system and to evaluate the signal provided by binding of membrane co-stimulatory molecules on tumour cells, freshly isolated tumour cells were irradiated with 150 Gy g-ray at a 15 Gy/min dose rate, then autologous CD4 1 T cells were incubated with them at a ratio of 10 : 1 for 48 h. This also led to an increase in Th17 cells (Fig. 3d, 4Á11-10Á69%) . Therefore, factors involved in antigen presentation such as 
The phenotypical features of T cells are altered by the tumour microenvironment
Given that Th17 cells accumulate in tumours in situ, it is possible that tumour cells and the tumour microenvironment play important roles in promoting Th17 cell development. However, are there Th17 cells that migrate into tumour microenvironments? To address this issue, chemokine expression of tumour cells was detected by real-time PCR. We found that tumour cells expressed higher levels of CCL20 but lower CCL5 and CCL19 (Fig. 4a, P < 0Á01) .
To assess further the relationship between Th17 and tumour cells, we identified the phenotypical features of Th17 and T regs in the tumour microenvironment. (Fig. 4b) . Similarly, increased CD4
Th17 cells were detected in the CD4 1 CD25 1 CD127 low T regs cultured with tumour cells (Fig. 4c) . These results suggest that the phenotypical features of T cells can be altered by tumour cells, and some Th17 cells and T regs may convert into each other in vitro.
Increased Th17 cells correlated positively with both T regs and B regs in PHC
To determine the relationship between Th17 and T regs in patients with PHC, we analysed the percentage of T regs and the ratio of T regs to Th17. The data show that the T regs were increased in PHC patients and increased with TNM stage progression (Supporting information, Fig. S5 ). We found the ratio in PHC was higher than that in normal controls, as shown in Fig. 5a (P < 0Á001). We also analysed the linear relationship between Th17 and T regs . As shown in Fig. 5b , Th17 and T regs showed a positive linear correlation and r 5 0Á52, P < 0Á001. To assess further the relationship between Th17 and B regs in PHC, we detected the percentage of CD19
increased percentage of B regs were detected in PHC and increased B regs were correlated positively with increased Th17 cells in PHC (r 5 0Á65, P < 0Á05, Fig. 5c ). These data . The mRNA expression of CCL20 was higher than that in NC (**P < 0Á01), while decreased CCL5 and CCL19 were detected in PHC (***P < 0Á001 and **P < 0Á01, respectively). emphasize that increased Th17 cells correlated positively with both T regs and B regs in PHC. We therefore hypothesized that there might be an interaction between Th17 cells and CD19 
Discussion
In this study, we detected that significantly increased Th17 cells in PHC peripheral blood correlated with TNM stages and accumulated in in-situ tumours of PHC. We showed that elevated expression of IL-17 production in the PHC cell-contact co-culture system and Th17 cells proliferation were promoted by tumour cells via cell-contact in PHC. As well, we were the first to show that increased Th17 cells correlated positively with both T regs and B regs in PHC. These results provide important information and new insights into Th17, T regs and B regs and other immune cells in the PHC tumour microenvironment. Although investigations into Th17 cells have been made for several years, the relationship between Th17 cells and cancer and their roles in anti-tumour immunity need to be explored further. Previous studies revealed that Th17 cells were elevated in patients with gastric cancer [21] , ovarian cancer [22] , cervical cancer [23] , colon cancer [24] , hepatocellular carcinoma [25, 26] and myeloma [27] . Inconsistent with these observations is that in some carcinomas, such as breast cancer, Th17 cells were lower than in healthy controls [28] . To determine the prevalence of Th17 cells in patients with PHC, we evaluated the Th17 cell population in the circulation or tumour micro-environment. Our study showed that the frequency of Th17 cells was increased predominantly in PBMC, and Th17 cells were associated with the PHC TNM stage progression. Th17 cells in TIL were higher than those in NIL and peripheral blood. In the present study we also observed that CD4
1 IL-17 1 Th17 cells were enriched predominantly in the tumour microenvironment. All these results suggest that Th17 cells might be involved in PHC progression. We show that tumour cells play important roles in promoting Th17 cells in the tumour microenvironment. We found that IL-6, IL-23 and TGF-b levels were increased in PHC and CD80 and CD86, ICOSL expression was increased in tumour cells. On the basis of these studies, we demonstrate that the increased proportion of Th17 cells could be attributed to the observed increased secretion of IL-6, IL-23 and TGF-b and the increased CD28-CD80/ CD86, ICOS-ICOSL contact. That is to say, the cytokines in the tumour microenvironment and the contact between tumour cells and CD4
1 T cells through co-stimulatory molecules were all involved in promoting Th17 cells. Although some data indicated that the production of IL-17A and IL-17F by T lymphocytes was regulated by IL-23 produced by dendritic cells, independently of cell-cellcontact or traditional T cell receptor (TCR) activation [29] , our study demonstrated that Th17 cells were increased via both cell-contact-independent and -dependent mechanisms in the tumour microenvironment, especially for cellcontact-dependent mechanisms, including co-stimulatory molecules. Our findings clearly support the emerging concept that tumour environmental factors drive the generation and expansion of Th17 cells through both cytokines and cell-contact. Our results show that tumour cells secrete several key cytokines and chemokines present an array of cell-contact signals, and form a microenvironment that regulates and prompts the proliferation of Th17 cells. The PHC microenvironment may convert CD4 T regs may be converted into IL-17-procucing cells in the tumour microenvironment, which is consistent with a previous study on ovarian cancer [30] . That is to say, the sources of Th17 cells in tumour tissues may include the trafficking of circulating Th17 cells to tumours and locally induced Th17 cells. T regs have been accepted widely as an important suppressive regulation in human tumours, contributing to tumour progression [31] . As well as the traditional T regs , a new discrete subset of B cells, described and confirmed as B regs [32] , has been brought into focus. Numerous researches [33, 34] Fig. 6 ), it is hypothesized that in the tumour microenvironment, tumour cells recruit Th17 cells, prompting the expansion and proliferation of Th17 cells (step 1) and some Th17 cells, and T regs may convert into each other (step 2); Th17 cells, which can also facilitate the generation of B regs (step 3), all of which impair the anti-tumour response, collaborate with tumour growth and promote immune escape in the tumour microenvironment (step 4). Of course, the precise involvement of Th17 cells, T regs and B regs in anti-tumour immunity needs to be elucidated further. These results may provide the basis and new clues for further investigation of the function and mechanisms of Th17, T regs and B regs in PHC and, possibly, other human tumours. 
Supporting information
Additional Supporting information may be found in the online version of this article at the publisher's web-site: were higher than those in non-tumour cells derived from non-tumour tissues, while CD86-positive cells (b) in tumour appeared to be lower than that in non-tumour. 
CD127
low cells correlated positively with FoxP3 in CD4 1 T cells of normal controls (r 2 5 0Á5662, *P < 0Á05, n 5 10). Fig. S4 . The sorting strategy of CD4 1 CD25 1 CD127 low regulatory T cells (T regs ) and CD4 1 CD25 -CD127 1 non-T regs . Cells stained with CD4 fluorescein isothiocyanate (FITC), CD25 allophycocyanin (APC) and CD127 phycoerythrin-cyanin 5Á5 (PE-Cy5Á5), T regs and non-T regs were gated as shown in plots. Representative plots showed that the T reg populations in the gated CD4 1 cells were increased in the patients with PHC in comparison to normal controls. (b) T regs in the PHC group (n 5 93) were higher than those in the NC group (n 5 51), the differences between NC and PHC were significant (***P < 0Á0001). (c) T regs were enhanced with PHC TNM stage progression, the percentage of T regs in advanced stages (stages III-IV, n 5 54) was higher than that in early stages (stages I-II, n 5 39) (**P < 0Á01). hi B regs were detected in B cells cultured with autologous Th17 (n 5 4, *P < 0Á05). Table S1 . Nuclear sequences of chemokine primes used in real-time polymerase chain reaction (PCR).
